Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Amortizatization of Intangibles: 2015-2024

Historic Amortizatization of Intangibles for Kura Oncology (KURA) over the last 10 years, with Dec 2024 value amounting to $13.1 million.

  • Kura Oncology's Amortizatization of Intangibles fell 44.02% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year change of. This contributed to the annual value of $13.1 million for FY2024, which is 39.50% up from last year.
  • According to the latest figures from FY2024, Kura Oncology's Amortizatization of Intangibles is $13.1 million, which was up 39.50% from $9.4 million recorded in FY2023.
  • Kura Oncology's 5-year Amortizatization of Intangibles high stood at $13.1 million for FY2024, and its period low was -$4.4 million during FY2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $9.4 million (2023), whereas its average is $7.0 million.
  • In the last 5 years, Kura Oncology's Amortizatization of Intangibles slumped by 970.98% in 2021 and then spiked by 685.09% in 2023.
  • Over the past 5 years, Kura Oncology's Amortizatization of Intangibles (Yearly) stood at -$410,000 in 2020, then tumbled by 970.98% to -$4.4 million in 2021, then skyrocketed by 63.33% to -$1.6 million in 2022, then surged by 685.09% to $9.4 million in 2023, then surged by 39.50% to $13.1 million in 2024.